ALDR’s innovation outlook is trending up based on a current score of 56 out of 99, outperforming sector average. Jobs growth over the past year has decreased and insiders sentiment is neutral. It is most exposed to Teva Pharmaceutical Industries Limited as its supplier. Over the past 4 quarters ALDR beat earnings estimates 2 times. For more analysis and articles visit our website.